The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews

被引：0
作者：
Suzanne Nielsen
Rada Germanos
Megan Weier
John Pollard
Louisa Degenhardt
Wayne Hall
Nicholas Buckley
Michael Farrell
机构：
[1] University of New South Wales Sydney,National Drug and Alcohol Research Centre
[2] The University of Queensland,Centre for Youth Substance Abuse Research
[3] Royal Brisbane and Women’s Hospital Brisbane,School of Medical Sciences
[4] The University of Sydney,undefined
来源：
Current Neurology and Neuroscience Reports | 2018年 / 18卷
关键词：
Multiple sclerosis; Cannabinoid; Pain; Spasticity; Nabiximols; Dronabinol; Cannabis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 217 条
  • [1] Compston A(2008)Multiple sclerosis Lancet 372 1502-1517
  • [2] Coles A(2015)Immunopathology of multiple sclerosis Nat Rev Immunol 15 545-558
  • [3] Dendrou CA(2005)Towards individualised multiple-sclerosis therapy Lancet Neurol 4 693-694
  • [4] Fugger L(2012)Individualizing treatment goals and interventions for people with MS Curr Opin Neurol 25 S20-S27
  • [5] Friese MA(2014)Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of Neurologists J Clin Neurosci 21 1857-1865
  • [6] Gold R(2014)Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of Neurologists J Clin Neurosci 21 1835-1846
  • [7] Hartung H-P(2014)Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of Neurologists J Clin Neurosci 21 1847-1856
  • [8] Giovannoni G(2003)Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial Lancet 362 1517-1526
  • [9] Rhoades RW(2004)Patterns of cannabis use among patients with multiple sclerosis Neurology 62 2098-2100
  • [10] Broadley SA(2011)Role of cannabinoids in multiple sclerosis CNS Drugs 25 187-201
12345678910